EUVIMEDEUVIMED entdecken
Crossref

A NEW HYPERFRACTIONATION EFFECT IN THEPHARMACOKINETICS OF DOPAMINERGIC AGONIST(CABERGOLINE) FOR THE LONG-TERM TREATMENT OFNON-FUNCTIONING PITUITARY TUMOURS

Gabriel Burstein

Acta Endocrinologica (Bucharest) · 2005

DOI: 10.4183/aeb.2005.121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Endocrinologica (Bucharest), 2005. Verfasst von Gabriel Burstein.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Burstein, G. (2005). A NEW HYPERFRACTIONATION EFFECT IN THEPHARMACOKINETICS OF DOPAMINERGIC AGONIST(CABERGOLINE) FOR THE LONG-TERM TREATMENT OFNON-FUNCTIONING PITUITARY TUMOURS. Acta Endocrinologica (Bucharest). https://doi.org/10.4183/aeb.2005.121

Vancouver

Burstein G. A NEW HYPERFRACTIONATION EFFECT IN THEPHARMACOKINETICS OF DOPAMINERGIC AGONIST(CABERGOLINE) FOR THE LONG-TERM TREATMENT OFNON-FUNCTIONING PITUITARY TUMOURS. Acta Endocrinologica (Bucharest). 2005. doi:10.4183/aeb.2005.121

BibTeX
@article{Burstein2005,
  author = {Burstein, Gabriel},
  title = {A NEW HYPERFRACTIONATION EFFECT IN THEPHARMACOKINETICS OF DOPAMINERGIC AGONIST(CABERGOLINE) FOR THE LONG-TERM TREATMENT OFNON-FUNCTIONING PITUITARY TUMOURS},
  journal = {Acta Endocrinologica (Bucharest)},
  year = {2005},
  doi = {10.4183/aeb.2005.121}
}
Kostenlos starten →